Sales Agreements in the Biotechnology Industry

423 Contracts & Agreements

Browse by Company

2seventy bio, Inc. (1 contract)
89bio, Inc. (1)
Acorda Therapeutics (1)
Actinium Pharmaceuticals, Inc. (3)
Acumen Pharmaceuticals, Inc. (1)
Acurx Pharmaceuticals, LLC (1)
Adagio Therapeutics, Inc. (1)
ADURO BIOTECH, INC. (2)
Advaxis, Inc. (1)
Adverum Biotechnologies, Inc. (1)
Aeglea BioTherapeutics, Inc. (2)
Aerovate Therapeutics, Inc. (1)
AGENUS INC (1)
AILERON THERAPEUTICS INC (1)
Akebia Therapeutics, Inc. (1)
ALBIREO PHARMA, INC. (2)
Alector, Inc. (1)
Alexion Pharmaceuticals (1)
Allakos Inc. (4)
Allarity Therapeutics, Inc. (1)
Allena Pharmaceuticals, Inc. (2)
Allogene Therapeutics, Inc. (1)
ALPINE IMMUNE SCIENCES, INC. (1)
Alzamend Neuro, Inc. (1)
AMARILLO BIOSCIENCES INC (2)
Amplitude Healthcare Acquisition Corp (1)
ANAVEX LIFE SCIENCES CORP. (2)
Annexon, Inc. (1)
Annovis Bio, Inc. (1)
Apellis Pharmaceuticals, Inc. (1)
Applied Molecular Transport Inc. (1)
Applied Therapeutics Inc. (1)
Aptinyx Inc. (1)
AQUINOX PHARMACEUTICALS, INC (1)
Aravive, Inc. (1)
ARCA biopharma, Inc. (10)
Arcturus Therapeutics Holdings Inc. (2)
Arcutis Biotherapeutics, Inc. (1)
ARDELYX, INC. (3)
Aridis Pharmaceuticals, Inc. (1)
ASSEMBLY BIOSCIENCES, INC. (1)
Atara Biotherapeutics, Inc. (5)
Athenex, Inc. (1)
AVEO PHARMACEUTICALS INC (2)
Avid Bioservices, Inc. (3)
Avidity Biosciences, Inc. (2)
Axovant Sciences Ltd. (3)
Beam Therapeutics Inc. (3)
Big Cypress Acquisition Corp. (1)
bioAffinity Technologies, Inc. (1)
BioCardia, Inc. (1)
BIOCEPT INC (1)
BIOMARIN PHARMACEUTICAL INC (1)
BioRestorative Therapies, Inc. (1)
BIOSPECIFICS TECHNOLOGIES CORP (1)
BIOTIME INC (2)
BIOVIE INC. (1)
bluebird bio, Inc. (1)
Blueprint Medicines Corp (2)
Calithera Biosciences, Inc. (2)
CareDx, Inc. (1)
CATABASIS PHARMACEUTICALS INC (2)
Celcuity Inc. (1)
Celldex Therapeutics, Inc. (2)
Celsion CORP (1)
Centessa Pharmaceuticals Ltd (1)
Chanticleer Holdings, Inc. (2)
Codiak BioSciences, Inc. (1)
CohBar, Inc. (2)
Coherus BioSciences, Inc. (3)
Conatus Pharmaceuticals Inc. (2)
Constellation Alpha Capital Corp. (1)
Corvus Pharmaceuticals, Inc. (2)
CTI BIOPHARMA CORP (1)
Cue Biopharma, Inc. (4)
CURIS INC (1)
Cyclacel Pharmaceuticals, Inc. (1)
CytoDyn Inc. (1)
Cytokinetics, Incorporated (2)
CYTORI THERAPEUTICS, INC. (1)
DBV Technologies S.A. (1)
DelMar Pharmaceuticals, Inc. (1)
Denali Therapeutics Inc. (9)
Dicerna Pharmaceuticals Inc (1)
Diffusion Pharmaceuticals Inc. (1)
DYNAVAX TECHNOLOGIES CORP (2)
Editas Medicine, Inc. (1)
Entasis Therapeutics Holdings Inc. (1)
Entera Bio Ltd. (2)
Entrada Therapeutics, Inc. (1)
Esperion Therapeutics, Inc. (1)
Evelo Biosciences, Inc. (1)
FATE THERAPEUTICS INC (1)
FIVE PRIME THERAPEUTICS INC (1)
Foghorn Therapeutics Inc. (1)
Fortress Biotech, Inc. (3)
Forty Seven, Inc. (4)
FS Development Corp. (1)
G1 Therapeutics, Inc. (1)
GENEREX BIOTECHNOLOGY CORP (1)
GERON CORP (3)
GLYCOMIMETICS INC (2)
GTX INC (1)
GX Acquisition Corp. (1)
HEAT BIOLOGICS, INC. (7)
HEMISPHERX BIOPHARMA INC (3)
HISTOGENICS CORP (4)
HUMANIGEN, INC (1)
IDEAYA Biosciences, Inc. (2)
IDERA PHARMACEUTICALS, INC. (2)
Immix Biopharma, Inc. (2)
IMMUNOMEDICS INC (1)
INFINITY PHARMACEUTICALS, INC. (3)
Inmune Bio, Inc. (4)
INOVIO PHARMACEUTICALS, INC. (6)
INSMED Inc (2)
Intec Pharma Ltd. (1)
INTERCEPT PHARMACEUTICALS, INC. (1)
INTREXON CORP (1)
Invitae Corp (3)
IO Biotech, Inc. (1)
Isoray, Inc. (1)
Jounce Therapeutics, Inc. (2)
KalVista Pharmaceuticals, Inc. (1)
Karyopharm Therapeutics Inc. (2)
Kezar Life Sciences, Inc. (1)
Kindred Biosciences, Inc. (1)
Krystal Biotech, Inc. (3)
Kura Oncology, Inc. (5)
LEAP THERAPEUTICS, INC. (1)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (1)
MACROGENICS INC (2)
MADRIGAL PHARMACEUTICALS, INC. (5)
MAIA Biotechnology, Inc. (1)
MANNKIND CORP (1)
MEDICINOVA INC (2)
MEI Pharma, Inc. (3)
Mersana Therapeutics, Inc. (3)
Millendo Therapeutics, Inc. (1)
Mirati Therapeutics, Inc. (1)
Mirum Pharmaceuticals, Inc. (1)
Moderna, Inc. (1)
Molecular Templates, Inc. (3)
Moleculin Biotech, Inc. (3)
Monopar Therapeutics (1)
MUSTANG BIO, INC. (5)
Myovant Sciences Ltd. (1)
NANOVIRICIDES, INC. (2)
NantKwest, Inc. (1)
NEWLINK GENETICS CORP (1)
NexImmune, Inc. (1)
NextCure, Inc. (1)
NOVAVAX INC (12)
Novus Therapeutics, Inc. (1)
Nuvalent, Inc. (1)
Olema Pharmaceuticals, Inc. (2)
OncoCyte Corp (1)
ONCOSEC MEDICAL Inc (1)
ORAGENICS INC (1)
Orchard Therapeutics plc (1)
ORGANOVO HOLDINGS, INC. (1)
Orgenesis Inc. (1)
Outlook Therapeutics, Inc. (1)
PepGen Inc. (1)
Pfenex Inc. (2)
PIERIS PHARMACEUTICALS, INC. (1)
PLURISTEM THERAPEUTICS INC (1)
POLARITYTE, INC. (1)
PROGENITY, INC. (1)
Protagenic Therapeutics, Inc. (1)
Protalix BioTherapeutics, Inc. (1)
PROTEOSTASIS THERAPEUTICS, INC. (2)
PTC THERAPEUTICS, INC. (1)
Radius Health, Inc. (5)
RECURSION PHARMACEUTICALS, INC. (1)
REGENXBIO Inc. (1)
Reneo Pharmaceuticals, Inc. (1)
Retrophin, Inc. (1)
Revolution Medicines, Inc. (1)
REXAHN PHARMACEUTICALS, INC. (2)
RHYTHM PHARMACEUTICALS, INC. (1)
RIGEL PHARMACEUTICALS INC (1)
RITTER PHARMACEUTICALS INC (1)
ROCKET PHARMACEUTICALS, INC. (2)
Sage Therapeutics, Inc. (1)
SANGAMO THERAPEUTICS, INC (2)
Savara Inc (1)
SELECTA BIOSCIENCES INC (1)
Seres Therapeutics, Inc. (3)
Shattuck Labs, Inc. (1)
SOLENO THERAPEUTICS INC (1)
Solid Biosciences Inc. (1)
SOLIGENIX, INC. (2)
SOPHIRIS BIO INC. (1)
Sorrento Therapeutics, Inc. (4)
Spectrum Pharmaceuticals, Inc. (14)
Spero Therapeutics, Inc. (1)
SpringWorks Therapeutics, Inc. (2)
Sun BioPharma, Inc. (1)
SUNESIS PHARMACEUTICALS INC (3)
Surface Oncology, Inc. (2)
Syndax Pharmaceuticals Inc (1)
SYNLOGIC, INC. (1)
Synthetic Biologics, Inc. (4)
T2 Biosystems, Inc. (1)
Taysha Gene Therapies, Inc. (1)
TENAX THERAPEUTICS, INC. (1)
Tenaya Therapeutics, Inc. (1)
TG THERAPEUTICS, INC. (1)
Tocagen Inc (2)
Tonix Pharmaceuticals Holding Corp. (1)
Tracon Pharmaceuticals, Inc. (2)
TScan Therapeutics, Inc. (1)
Twist Bioscience Corp (1)
Ultragenyx Pharmaceutical Inc. (2)
uniQure N.V. (3)
Unity Biotechnology, Inc. (3)
UroGen Pharma Ltd. (1)
Vaxart, Inc. (1)
Vaxcyte, Inc. (1)
Verastem, Inc. (1)
Vericel Corp (1)
VICAL INC (1)
Viking Therapeutics, Inc. (2)
Virios Therapeutics, LLC (1)
VITAL THERAPIES INC (3)
VITRO DIAGNOSTICS INC (1)
Vor Biopharma Inc. (1)
vTv Therapeutics Inc. (2)
WINDTREE THERAPEUTICS INC (2)
XBiotech Inc. (1)
Xencor Inc (1)
Xenetic Biosciences, Inc. (1)
Xenon Pharmaceuticals Inc. (5)
XOMA Corp (3)
ZAFGEN, INC. (1)

Recent Contracts

Amendment, dated April 12, 2024, to Sales Agreement, dated May 16, 2023, by and between the Company and BTIG (Outlook Therapeutics, Inc., Filed With SEC on April 12, 2024)
At Market Issuance Sales Agreement by and between NanoViricides, Inc. and EF Hutton LLC (NANOVIRICIDES, INC., Filed With SEC on April 5, 2024)
Sales Agreement, dated March 22, 2024, by and between Lineage Cell Therapeutics, Inc. and B. Riley Securities, Inc (BIOTIME INC, Filed With SEC on March 22, 2024)
At-The-Market Issuance Sales Agreement, dated March 19, 2024, by and between Allarity Therapeutics, Inc. and Ascendiant Capital Markets, LLC (Allarity Therapeutics, Inc., Filed With SEC on March 20, 2024)
Amended and Restated Sales Agreement, dated March 13, 2024, by and between the Company and Jefferies LLC (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
Amendment No. 1 to Sales Agreement, dated as of February 29, 2024, between Rhythm Pharmaceuticals, Inc. and Cowen and Company, LLC (RHYTHM PHARMACEUTICALS, INC., Filed With SEC on February 29, 2024)
Sales Agreement, dated February 28, 2024, by and between vTv Therapeutics Inc. and Cowen and Company, LLC (vTv Therapeutics Inc., Filed With SEC on February 28, 2024)
Sales Agreement, dated February 28, 2024, by and between the Company and Cowen and Company, LLC (Mersana Therapeutics, Inc., Filed With SEC on February 28, 2024)
Sales Agreement, dated February 27, 2024, by and between SpringWorks Therapeutics, Inc. and Cowen and Company, LLC (SpringWorks Therapeutics, Inc., Filed With SEC on February 27, 2024)
Sales Agreement, dated February 26, 2024, by and between Celldex Therapeutics, Inc. and Cantor Fitzgerald & Co (Celldex Therapeutics, Inc., Filed With SEC on February 26, 2024)
Sales Agreement, dated as of February 22, 2024, between Leerink Partners LLC and Insmed Incorporated (INSMED Inc, Filed With SEC on February 22, 2024)
Sales Agreement by and between MEI Pharma, Inc. and JonesTrading Institutional Services LLC, dated as of February 20, 2024 (MEI Pharma, Inc., Filed With SEC on February 21, 2024)
Sales Agreement, dated February 13, 2024, by and between the Company and A.G.P (PLURISTEM THERAPEUTICS INC, Filed With SEC on February 13, 2024)
Controlled Equity Offering Sales Agreement, dated as of January 26, 2024 by and between Cantor Fitzgerald & Co. and SAB Biotherapeutics, Inc (Big Cypress Acquisition Corp., Filed With SEC on January 26, 2024)
Open Market Sales Agreement, dated as of January 19, 2024, by and between the Company and Jefferies LLC (IDEAYA Biosciences, Inc., Filed With SEC on January 19, 2024)
Sales Agreement by and between Registrant and Cowen and Company, LLC, dated January 5, 2024 (Olema Pharmaceuticals, Inc., Filed With SEC on January 5, 2024)
Controlled Equity OfferingSM Sales Agreement by and between the Company and Cantor Fitzgerald & Co., dated December 22, 2023 (Adagio Therapeutics, Inc., Filed With SEC on December 22, 2023)
Sales Agreement, dated December 8, 2023, by and between NightHawk Biosciences, Inc. and A.G.P./Alliance Global Partners (HEAT BIOLOGICS, INC., Filed With SEC on December 8, 2023)
Sales Agreement, dated as of November 15, 2023, between the Company and A.G.P./Alliance Global Partners (Acurx Pharmaceuticals, LLC, Filed With SEC on November 15, 2023)
Sales Agreement, dated November 13, 2023, by and between the Registrant and Leerink Partners LLC (Reneo Pharmaceuticals, Inc., Filed With SEC on November 13, 2023)
Sales Agreement, dated November 7, 2023, by and between Alector, Inc., and Cowen and Company, LLC (Alector, Inc., Filed With SEC on November 7, 2023)
Sales Agreement, dated as of November 7, 2023, by and between the Company and Cowen and Company, LLC (Sage Therapeutics, Inc., Filed With SEC on November 7, 2023)
Amendment No. 2 to Sales Agreement between Coherus BioSciences, Inc. and Cowen and Company, LLC dated September 11, 2023 (Coherus BioSciences, Inc., Filed With SEC on November 6, 2023)
At Market Issuance Sales Agreement, dated November 1, 2023, between Geron Corporation and B. Riley Securities, Inc (GERON CORP, Filed With SEC on November 2, 2023)
Sales Agreement by and between the Registrant, Leerink Partners LLC and Cantor Fitzgerald & Co., dated November 2, 2023 (Mirum Pharmaceuticals, Inc., Filed With SEC on November 2, 2023)
Amendment No. 2 to Sales Agreement, dated November 2, 2023, by and between the Registrant and Cowen and Company, LLC (Allogene Therapeutics, Inc., Filed With SEC on November 2, 2023)
Sales Agreement, dated November 2, 2023, by and among the Registrant, Leerink Partners LLC and Cantor Fitzgerald & Co (Kura Oncology, Inc., Filed With SEC on November 2, 2023)
Sales Agreement, dated November 1, 2023, by and between Atara Biotherapeutics, Inc. and Cowen and Company, LLC (Atara Biotherapeutics, Inc., Filed With SEC on November 1, 2023)
Sales Agreement, dated as of November 1, 2023, by and between Apellis Pharmaceuticals, Inc. and Cowen and Company, LLC (Apellis Pharmaceuticals, Inc., Filed With SEC on November 1, 2023)
Sales Agreement, by and between Entrada Therapeutics, Inc. and Cowen and Company, LLC, dated as of September 29, 2023 (Entrada Therapeutics, Inc., Filed With SEC on September 29, 2023)
Equipment Usage Attachment, dated effective as of August 9, 2019, by and between Gen-Probe Sales & Service, Inc., together with its subsidiaries and affiliates and Village Oaks... (bioAffinity Technologies, Inc., Filed With SEC on September 20, 2023)
Sales Agreement (DelMar Pharmaceuticals, Inc., Filed With SEC on September 19, 2023)
Amendment No. 1 to Sales Agreement, dated as of September 12, 2023, between Rocket Pharmaceutical Inc. and Cowen and Company, LLC (ROCKET PHARMACEUTICALS, INC., Filed With SEC on September 13, 2023)
At-The-Market Issuance Sales Agreement, dated September 8, 2023, with Ascendiant Capital Markets, LLC (Alzamend Neuro, Inc., Filed With SEC on September 8, 2023)
Sales Agreement, dated September 1, 2023, by and between MAIA Biotechnology, Inc. and ThinkEquity LLC (MAIA Biotechnology, Inc., Filed With SEC on September 1, 2023)
ATM Equity OfferingSM Sales Agreement, dated as of September 1, 2023, between BofA Securities, Inc. and REGENXBIO Inc (REGENXBIO Inc., Filed With SEC on September 1, 2023)
Amendment No. 1 to At-the-Market Sales Agreement, dated August 16, 2023, between INmune Bio Inc., and BTIG, LLC (Inmune Bio, Inc., Filed With SEC on August 16, 2023)
Sales Agreement, dated August 11, 2023, by and between the Company and Leerink Partners LLC (Applied Therapeutics Inc., Filed With SEC on August 11, 2023)
At-The-Market Equity Offering Sales Agreement by and between the Company and Stifel, Nicolaus & Company, Incorporated, dated August 8, 2023 (PepGen Inc., Filed With SEC on August 8, 2023)
Open Market Sales Agreement dated August 8, 2023 by and between the Registrant and Jefferies LLC (RECURSION PHARMACEUTICALS, INC., Filed With SEC on August 8, 2023)